Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.
Low
697.40
High
1,097.90
Low
914.35
High
939.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|
| 1 | Windlas Biotech Limited | 917.00 | -1.77% | 29.43 | 31.16 | 1,892 | 1,097.90 | 697.40 |
| 2 | Aarti Drugs Limited | 412.10 | +0.32% | 19.67 | 20.93 | 3,755 | 534.55 | 318.95 |
| 3 | Aarti Pharmalabs Limited | 872.50 | +1.14% | 37.11 | 23.50 | 7,904 | 946.10 | 585.00 |
| 4 | Abbott India Limited | 26,555.00 | -1.23% | 34.97 | 759.88 | 56,385 | 33,495.00 | 25,150.00 |
| 5 | ANLON HEALTHCARE LIMITED | 14.50 | +0.00% | 21.31 | 0.68 | 770 | 17.27 | 9.08 |
| 6 | Ajanta Pharma Limited | 3,725.00 | +0.18% | 41.01 | 90.83 | 46,547 | 3,796.00 | 2,329.90 |
| 7 | AKUMS DRUGS AND PHARMA L | 747.50 | +0.33% | 39.16 | 19.05 | 11,444 | 775.00 | 409.30 |
| 8 | Alivus Life Sciences Limited | 1,390.00 | -0.31% | 28.68 | 49.03 | 17,287 | 1,418.00 | 819.00 |
| 9 | Alkem Laboratories Limited | 5,470.00 | +1.80% | 30.31 | 180.45 | 65,372 | 5,933.50 | 5,075.00 |
| 10 | Amrutanjan Health Care Limited | 494.10 | +0.80% | 26.48 | 18.67 | 1,433 | 790.95 | 482.80 |
| 11 | Alembic Pharmaceuticals Limited | 826.15 | +0.38% | 23.42 | 35.27 | 16,239 | 1,002.00 | 635.80 |
| 12 | AstraZeneca Pharma India Limited | 7,655.50 | +0.20% | 112.92 | 67.85 | 19,154 | 9,849.50 | 7,551.50 |
| 13 | Aurobindo Pharma Limited | 1,635.80 | +0.60% | 25.58 | 64.00 | 94,195 | 1,682.40 | 1,016.10 |
| Median: 13 Co. | 917.00 | 0.32% | 29.43 | 35.27 | 16,239 | 1,097.90 | 697.40 |